To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
 
  •  

Q1: Infy beats estimates, net profit down by 5pc

Infosys
Mumbai, Jul 10: The much awaited Q1 results of India's leading IT firm, Infosys was announced on Friday, Jul 10. The giant's Q1 net profit is down by 5 per cent, but failed to disappoint the markets as it was better than the expected numbers.

For the first quarter (Q1) that ended Jun 30 PAT (profit after tax) is at Rs 1,527 crores, a decline of 5 per cent from the net profit of 1,613 crores posted in the fourth quarter (Q4) of last fiscal.

The company's net sales was at Rs 5,472 crores as opposed to the previous numbers at Rs 5,636 crores (QoQ). This accounts for a dip of 3 per cent in the net sales.
  Read:  தமிழில் 
The net profit of Infosys on a year on year basis (YoY) rose to Rs 1,527 crores in Apr-Jun, from Rs 1,302 crores.

With these positive results, Infosys has started off the day in the markets on a positive note and expected to push up the benchmark indices for the session.

OneIndia News
 
Connect with

Biotechnology major Biocon forays into nephrology space

Bangalore, Mar 09:  Biotechnology major Biocon on Thursday forayed into the nephrology space with the launch of a portfolio of five renal therapy products for the domestic and global markets, which it said was cheaper compared to MNC drug prices. The new immunosuppressants for renal therapy are at least 35-40 per cent cheaper than the MNC drug prices in the similar product category, the company's Marketing Head Rakesh Bamzai said.The Bangalore-headquartered company's Chairman and Managing Director, Kiran Mazumdar-Shaw said.....
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login